Catalyst Wire Dossier Catalyst Wire Dossier

ESHAP regimen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ESHAP regimen, covering 2011-10-06 to 2016-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma [Phase 2]

See pricing